Profile
LIMN VRTX REGN SGEN ALNY ARGX
Company Name Liminatus Pharma, Inc. Class A Common Stock Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $623.83M $116.96B $54.11B $43.15B $38.15B $33.66B
Employees 0.00K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Chris Kim J.D., L.L.M. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., M.D. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
Trading
LIMN VRTX REGN SGEN ALNY ARGX
Last Close $23.98 $445.82 $520.29 $228.74 $321.94 $560.53
High 52 $26.67 $516.74 $1201.76 $228.74 $325 $671.75
Low 52 $4.56 $396.64 $482.92 $228.74 $224.58 $430.04
Price vs. 52 Week High -10.09 % -13.72 % -56.71 % 0 % -0.94 % -16.56 %
Price vs. 52 Week Low 425.88 % 12.4 % 7.74 % 0 % 43.35 % 30.34 %
Total Return
LIMN VRTX REGN SGEN ALNY ARGX
1 Month Return 331.29 % 2.25 % -11.57 % 0 % 11.03 % -4.61 %
3 Month Return 0 % -10.89 % -18.72 % 0 % 19.59 % -3.96 %
6 Month Return 0 % 8.56 % -27.4 % 0 % 32.76 % -11.31 %
9 Month Return 0 % -3.74 % -49.97 % 0 % 17.25 % 6.85 %
YTD Return 0 % 10.71 % -26.96 % 0 % 36.82 % -8.86 %
1 Year Return 0 % -5.95 % -51.34 % 0 % 31.31 % 25.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
LIMN VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.35 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
LIMN VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM - -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM - -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM - -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 100 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM - -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM - 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM - 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM - -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM - -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM - 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM - 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM - -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM - -92.97 17.92 -81.26 -506.05 -433.65
Price To Operating Cash Flows Ratio TTM - -119.36 13.76 -93.1 -841.05 -515.25
Price Cash Flow Ratio TTM - -119.36 13.76 -93.1 -841.05 -515.25
Income Statement (TTM)
LIMN VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -4.05 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
LIMN VRTX REGN SGEN ALNY ARGX
Long Term Debt $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
LIMN VRTX REGN SGEN ALNY ARGX
Net Income $-0B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $0B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 40.4999
AARD Aardvark Therapeutics, Inc. Common Stock 13.9434
ABCL AbCellera Biologics Inc. 3.748
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.0156
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.23
ABPWW 0.0292
ABSI Absci Corporation 2.695
ABUS Arbutus Biopharma Corporation 3.215
ABVC ABVC BioPharma, Inc. 2.229
ABVX Abivax SA American Depositary Shares 7.08
ACAD ACADIA Pharmaceuticals Inc. 22.505
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.65
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.65
ACIU AC Immune SA 2.11
Unlock